Related articles:

Five Prime Therapeutics Inc.: Five Prime Announces Fourth Quarter and Full Year 2016 Financial Results
February 23, 2017

Five Prime Therapeutics Inc.: Five Prime Therapeutics to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 3
October 20, 2016

Five Prime Therapeutics Inc.: Five Prime Therapeutics to Present at the Morgan Stanley Global Healthcare Conference
September 06, 2016

Five Prime Therapeutics Inc.: Five Prime Announces Second Quarter 2016 Results and Provides Business Update
August 04, 2016

Five Prime Therapeutics Inc.: Five Prime Therapeutics Appoints Dr. Robert Sikorski as Chief Medical Officer
June 01, 2016

Five Prime Therapeutics Inc.: Five Prime Therapeutics Announces Updated Clinical Data on FPA144 and FP-1039 to be Presented during 2016 ASCO Annual Meeting
May 18, 2016

Five Prime Therapeutics Inc.: Five Prime Announces First Quarter 2016 Results and Provides Business Update
May 05, 2016

Five Prime Therapeutics Inc.: Five Prime Therapeutics to Announce First Quarter 2016 Financial Results and Host Conference Call on May 5
April 21, 2016

Five Prime Therapeutics Inc.: Five Prime Therapeutics Announces Changes to Board of Directors
March 16, 2016

Five Prime Therapeutics Inc.: Five Prime Announces Fourth Quarter and Full Year 2015 Financial Results
March 10, 2016

Five Prime Therapeutics Inc.: Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2015 Financial Results and Host Conference Call on March 10
February 26, 2016

Five Prime Therapeutics Inc.: Five Prime Therapeutics Announces Key Executive Appointments
February 01, 2016

Five Prime Therapeutics Inc.: Five Prime Therapeutics Appoints Drug Development Leaders to Board of Directors
December 03, 2015

Five Prime Therapeutics Inc.: Five Prime Therapeutics Reports Third Quarter 2015 Results and Provides Business Update
November 04, 2015

Five Prime Therapeutics Inc.: Five Prime Therapeutics to Announce Third Quarter 2015 Financial Results and Host Conference Call on November 4
October 28, 2015

Five Prime Therapeutics Inc.: Five Prime Therapeutics Reports Second Quarter 2015 Results and Provides Business Update
August 06, 2015

Five Prime Therapeutics Inc.: Five Prime Therapeutics to Announce Second Quarter 2015 Financial Results and Host Conference Call on August 6
July 31, 2015

Five Prime Therapeutics Inc.: Five Prime Therapeutics Establishes Strategic Research Collaboration and License Agreement With Inhibrx for Novel GITR Antibodies
July 15, 2015

Five Prime Therapeutics Inc.: bluebird bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy
May 26, 2015

Five Prime Therapeutics Inc.: Five Prime Therapeutics Announces First Quarter 2015 Financial Results
May 13, 2015

Five Prime Therapeutics Inc.: Five Prime Therapeutics to Announce First Quarter 2015 Financial Results and Host Conference Call on May 13
May 07, 2015

Five Prime Therapeutics Inc.: Five Prime Therapeutics Announces Fourth Quarter and Full Year 2014 Financial Results
March 17, 2015

Five Prime Therapeutics Inc.: Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2014 Financial Results and Host Conference Call on March 17
March 10, 2015

Five Prime Therapeutics Inc.: Five Prime Therapeutics Announces Third Quarter 2014 Financial Results
November 10, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics to Announce Third Quarter 2014 Financial Results and Host Conference Call on November 10
November 03, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics Announces Expansion of Respiratory Disease Research Collaboration and License Agreement With GSK
October 23, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics Appoints Bill Ringo to Its Board of Directors
October 02, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics Appoints Dr. Robert Sikorski as Vice President of Global Clinical Development
September 17, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics Announces Second Quarter 2014 Financial Results
August 05, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics Announces First Quarter 2014 Financial Results
May 08, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics to Announce First Quarter 2014 Financial Results and Host Conference Call on May 8
May 01, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics Announces Fourth Quarter and Fiscal 2013 Financial Results
March 25, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2013 Financial Results and Host Conference Call on March 25
March 18, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways
March 17, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics Announces Closing of Public Offering
February 12, 2014

Five Prime Therapeutics Inc.: Five Prime Announces the Full Exercise of the Underwriters' Option to Purchase Additional Shares
February 10, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics Prices Public Offering of Common Stock
February 06, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics Enters Into Antibody Research Collaboration Agreement With Adimab
January 09, 2014

Five Prime Therapeutics Inc.: Five Prime Therapeutics Announces Third Quarter 2013 Financial Results
November 12, 2013